Mona S Awadalla1, Kathryn P Burdon2, Emmanuelle Souzeau1, John Landers1, Alex W Hewitt3, Shiwani Sharma1, Jamie E Craig1. 1. Department of Ophthalmology, Flinders University, Flinders Medical Centre, Adelaide, South Australia, Australia. 2. Department of Ophthalmology, Flinders University, Flinders Medical Centre, Adelaide, South Australia, Australia2now also with Menzies Research Institute Tasmania, University of Tasmania, Tasmania, Australia. 3. now also with Menzies Research Institute Tasmania, University of Tasmania, Tasmania, Australia3Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, Melbourne, Victoria, Australia.
Abstract
IMPORTANCE: Nanophthalmos is a congenital disorder characterized by small eyes, with the main complications being severe hyperopia and angle-closure glaucoma. OBJECTIVE: To perform a clinical and genetic investigation of a large white family with autosomal dominant nanophthalmos. DESIGN, SETTING, AND PARTICIPANTS: Detailed clinical evaluation and a genome-wide linkage scan was conducted in the family NNO-SA1. Linkage was evaluated with a 10K single-nucleotide polymorphism array, followed by whole exome sequencing, to identify novel segregating coding variants within the linked region. The candidate gene was screened for mutations in additional independent families by direct sequencing of the coding exons and intron/exon boundaries. The expression pattern of the candidate gene in ocular tissues was analyzed by reverse transcriptase-polymerase chain reaction. Participants were recruited through ophthalmology clinics at Flinders Medical Centre, Adelaide, South Australia, Australia. Nanophthalmos was defined as an axial length less than 20.0 mm and/or refractive error greater than +7.00. Of the 35 available individuals from family NNO-SA1, 16 participants (46%) had a diagnosis of nanophthalmos, with mean refraction of +11.8 D and mean axial length of 17.6 mm. Unaffected unrelated individuals serving as controls were screened for the identified mutation. Additional independent families with clinically diagnosed nanophthalmos were also recruited. MAIN OUTCOMES AND MEASURES: Nanophthalmos status. RESULTS: Significant linkage was detected on chromosome 17 between single-nucleotide polymorphism markers rs2323659 and rs967293, with a maximum location score of 4.1. Exome sequencing identified a single novel segregating missense variant within the linkage region located in exon 8 of the transmembrane-98 (TMEM98) gene c.577G>C (p.Ala193Pro), which was absent in the Exome Variant Server database and among 285 local white individuals serving as controls. The TMEM98 gene was expressed in all ocular tissues tested including sclera and optic nerve head. CONCLUSIONS AND RELEVANCE: A novel gene associated with nanophthalmos, TMEM98 most likely represents the cause of the disease in this family. To our knowledge, this represents the first gene identified causing autosomal dominant nanophthalmos.
IMPORTANCE: Nanophthalmos is a congenital disorder characterized by small eyes, with the main complications being severe hyperopia and angle-closure glaucoma. OBJECTIVE: To perform a clinical and genetic investigation of a large white family with autosomal dominant nanophthalmos. DESIGN, SETTING, AND PARTICIPANTS: Detailed clinical evaluation and a genome-wide linkage scan was conducted in the family NNO-SA1. Linkage was evaluated with a 10K single-nucleotide polymorphism array, followed by whole exome sequencing, to identify novel segregating coding variants within the linked region. The candidate gene was screened for mutations in additional independent families by direct sequencing of the coding exons and intron/exon boundaries. The expression pattern of the candidate gene in ocular tissues was analyzed by reverse transcriptase-polymerase chain reaction. Participants were recruited through ophthalmology clinics at Flinders Medical Centre, Adelaide, South Australia, Australia. Nanophthalmos was defined as an axial length less than 20.0 mm and/or refractive error greater than +7.00. Of the 35 available individuals from family NNO-SA1, 16 participants (46%) had a diagnosis of nanophthalmos, with mean refraction of +11.8 D and mean axial length of 17.6 mm. Unaffected unrelated individuals serving as controls were screened for the identified mutation. Additional independent families with clinically diagnosed nanophthalmos were also recruited. MAIN OUTCOMES AND MEASURES: Nanophthalmos status. RESULTS: Significant linkage was detected on chromosome 17 between single-nucleotide polymorphism markers rs2323659 and rs967293, with a maximum location score of 4.1. Exome sequencing identified a single novel segregating missense variant within the linkage region located in exon 8 of the transmembrane-98 (TMEM98) gene c.577G>C (p.Ala193Pro), which was absent in the Exome Variant Server database and among 285 local white individuals serving as controls. The TMEM98 gene was expressed in all ocular tissues tested including sclera and optic nerve head. CONCLUSIONS AND RELEVANCE: A novel gene associated with nanophthalmos, TMEM98 most likely represents the cause of the disease in this family. To our knowledge, this represents the first gene identified causing autosomal dominant nanophthalmos.
Authors: Rose Richardson; Jane Sowden; Christina Gerth-Kahlert; Anthony T Moore; Mariya Moosajee Journal: Eur J Hum Genet Date: 2017-01-18 Impact factor: 4.246
Authors: Owen M Siggs; Mona S Awadalla; Emmanuelle Souzeau; Sandra E Staffieri; Lisa S Kearns; Kate Laurie; Abraham Kuot; Ayub Qassim; Thomas L Edwards; Michael A Coote; Erica Mancel; Mark J Walland; Joanne Dondey; Anna Galanopoulous; Robert J Casson; Richard A Mills; Daniel G MacArthur; Jonathan B Ruddle; Kathryn P Burdon; Jamie E Craig Journal: Clin Genet Date: 2020-03-05 Impact factor: 4.438
Authors: Sally H Cross; Lisa Mckie; Margaret Keighren; Katrine West; Caroline Thaung; Tracey Davey; Dinesh C Soares; Luis Sanchez-Pulido; Ian J Jackson Journal: Invest Ophthalmol Vis Sci Date: 2019-07-01 Impact factor: 4.799
Authors: David Khorram; Michael Choi; Ben R Roos; Edwin M Stone; Teresa Kopel; Richard Allen; Wallace L M Alward; Todd E Scheetz; John H Fingert Journal: Mol Vis Date: 2015-09-01 Impact factor: 2.367
Authors: Ross F Collery; Peter J Volberding; Jonathan R Bostrom; Brian A Link; Joseph C Besharse Journal: Invest Ophthalmol Vis Sci Date: 2016-12-01 Impact factor: 4.799
Authors: Abraham Kuot; Alex W Hewitt; Grant R Snibson; Emmanuelle Souzeau; Richard Mills; Jamie E Craig; Kathryn P Burdon; Shiwani Sharma Journal: PLoS One Date: 2017-08-23 Impact factor: 3.240